Gene · 10765
Papers2,218
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,218
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FTHL17, PRM2, CABYR, CPXCR1, ADAM29, and CABS1 are highly expressed in colon cancer patients and are regulated in vitro by epigenetic alterations. | Heliyon | 2024 | 38187237 | PubTator, text mining | PubMed |
| KDM5B predicts temozolomide-resistant subclones in glioblastoma. | iScience | 2024 | 38174322 | PubTator, text mining | PubMed |
| Effect of ubiquitin protease system on DNA damage response in prostate cancer (Review). | Exp Ther Med | 2024 | 38125344 | PubTator, text mining | PubMed |
| Lysine demethylase 5B (KDM5B): A key regulator of cancer drug resistance. | J Biochem Mol Toxicol | 2024 | 38014925 | PubTator, text mining | PubMed |
| JARID1B represses the osteogenic potential of human periodontal ligament mesenchymal cells. | Oral Dis | 2024 | 37994179 | PubTator, text mining | PubMed |
| Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma. | J Pathol Clin Res | 2024 | 37974379 | PubTator, text mining | PubMed |
| Five years of experience in the Epigenetics and Chromatin Clinic: what have we learned and where do we go from here? | Hum Genet | 2024 | 36952035 | PubTator, text mining | PubMed |
| Recent insights into crosstalk between genetic parasites and their host genome. | Brief Funct Genomics | 2024 | 36307128 | PubTator, text mining | PubMed |
| NUP98 rearrangements in AML: molecular mechanisms and clinical implications. | Onco (Basel) | 2023 | 42164049 | PubTator, text mining | PubMed |
| Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. | Front Immunol | 2023 | 38268926 | PubTator, text mining | PubMed |
| Plasma Circular-RNA 0005567 as a Potential Marker of Disease Activity in Rheumatoid Arthritis. | Int J Mol Sci | 2023 | 38203588 | PubTator, text mining | PubMed |
| A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancer. | J Gastrointest Oncol | 2023 | 38196539 | PubTator, text mining | PubMed |
| Heterozygous Knockout of ARID4B Using CRISPR/Cas9 Attenuates Some Aggressive Phenotypes in a Breast Cancer Cell Line. | Genes (Basel) | 2023 | 38137006 | PubTator, text mining | PubMed |
| Duplication at 19q13.32q13.33 Segregating with Neuropsychiatric Phenotype in a Three-Generation Family: Towards the Definition of a Critical Region. | Genes (Basel) | 2023 | 38136979 | PubTator, text mining | PubMed |
| Dynamic altruistic cooperation within breast tumors. | Mol Cancer | 2023 | 38093346 | PubTator, text mining | PubMed |
| Cancer stem cell-immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet. | Front Immunol | 2023 | 38090567 | PubTator, text mining | PubMed |
| Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer. | J Mammary Gland Biol Neoplasia | 2023 | 38066300 | PubTator, text mining | PubMed |
| The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease. | Epigenetics Chromatin | 2023 | 38057834 | PubTator, text mining | PubMed |
| The SMYD3-dependent H3K4me3 status of IGF2 intensifies local Th2 differentiation in CRSwNP via positive feedback. | Cell Commun Signal | 2023 | 38037054 | PubTator, text mining | PubMed |
| Systematic analysis of DNA methylation-mediated TF dysregulation on lncRNAs reveals critical roles in tumor immunity. | Mol Ther Nucleic Acids | 2023 | 38028194 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10765/papers?page=8